The Precision Peptide Genetic Test ($99 add-on, $298 standalone) does not predict whether you will respond to tirzepatide or guarantee weight loss
Frohman LA, Kineman RD
Acting on the Brain: It targets appetite centers in the brain to reduce hunger and calorie intake
Our team handles the logistics of your GLP-1 therapy so you can focus on your transformation without the stress of a difficult commute
Metabolic Markers and Lab Assessments That Guide Prescription Decisions The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
